Henry Schein, Inc. HSIC
86.37
0.84
0.98%
as of 25 Sep
- Market cap
- $9.5B
- P/E
- 25.0×
Follow HSIC
Indexes
indicate stock being part of an index,
Insider Buys
alert about insiders buying in the last 12 month
Henry Schein, Inc. (HSIC) Net margin
Henry Schein, Inc.'s net margin over the twelve months to 30 June 2026 was 2.96%, down 0.1 percentage points from fiscal 2025 (3.02%). Over the past ten years it has ranged from 3.02% (fiscal 2025) to 6.96% (fiscal 2019) — the current reading is the lowest in ten years. That is above the Medical Distribution industry median of −6.08% and above the Healthcare sector median of 0.00%.
Net margin, annual
Annual
| Period | Net margin | Change (points) |
|---|---|---|
| FY2025 | 3.02% | (0.06) |
| FY2024 | 3.08% | (0.29) |
| FY2023 | 3.37% | (0.88) |
| FY2022 | 4.25% | (0.84) |
| FY2021 | 5.09% | 1.10 |
| FY2020 | 3.99% | (2.97) |
| FY2019 | 6.96% | 1.27 |
| FY2018 | 5.69% | 1.12 |
| FY2017 | 4.57% | 0.19 |
| FY2016 | 4.38% | (0.13) |
Quarterly
| Period | Net margin | Change (points) |
|---|---|---|
| Jun 2026 | 2.72% | (0.46) |
| Mar 2026 | 3.18% | 0.24 |
| Dec 2025 | 2.94% | (0.08) |
| Sep 2025 | 3.02% | 0.37 |
| 42 more quarters | Free account |
Against its own ten years
Low 3.02%
High 6.96%
Ten-year median
4.38%
Current reading's percentile
9
Net margin against peers
| Company | Net margin |
|---|---|
| HSIC Henry Schein, Inc. | 2.96% |
| MCK McKesson Corporation compare | 1.12% |
| COR Cencora, Inc. compare | 0.79% |
| CAH Cardinal Health, Inc. compare | 0.67% |
| YI 111, Inc. Sponsored ADR compare | −0.75% |
| ACH Accendra Health, Inc. compare | −11.4% |
| COSM Cosmos Health Inc. compare | −33.1% |
| FOCL FocalTherics compare | −50.1% |
| AHG Akso Health Group Sponsored ADR compare | −61.3% |
| Medical Distribution industry median | −6.08% |
| Healthcare sector median | 0.00% |
| Market median | 0.55% |
What Net margin is
Net Profit Margin tells an investor how much of each unit of revenue ends up as profit for shareholders after all costs, interest and taxes.
Net Income Allotted to Shareholders ÷ Revenue
More on HSIC
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement